{"id":60841,"title":"Current and potential epigenetic targets in multiple myeloma.","abstract":"Despite recent advances in therapy, subgroups of multiple myeloma continue to have a poor prognosis. Numerous epigenetic changes have been described and occur as both etiologic and secondary events, making myeloma a good disease in which to understand the role of epigenetic therapies. Here, we describe a number of current and potential epigenetic targets in myeloma. ","date":"2014-05-09","categories":"Hemic and Lymphatic Diseases","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/24811790","annotations":[{"name":"Disease","weight":0.804197,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Therapy","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Etiology","weight":0.651478,"wikipedia_article":"http://en.wikipedia.org/wiki/Etiology"},{"name":"Prognosis","weight":0.579861,"wikipedia_article":"http://en.wikipedia.org/wiki/Prognosis"},{"name":"Multiple myeloma","weight":0.49665,"wikipedia_article":"http://en.wikipedia.org/wiki/Multiple_myeloma"},{"name":"Epigenetics","weight":0.202918,"wikipedia_article":"http://en.wikipedia.org/wiki/Epigenetics"},{"name":"High school","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/High_school"}]}
